LEONORI Lorenzo

Département de médecine interne > Service de rhumatologie

See author's contact details

Main Referenced Co-authors

Reginster, Jean-Yves (7)

Bruyère, Olivier (6)

Leroy, Mathieu (5)

Malaise, Michel (5)

Malaise, Olivier (5)

Main Referenced Keywords

Humans (2); Osteoporosis (2); Rheumatology (2); Absorptiometry, Photon (1); Aged (1);

Main Referenced Disciplines

Rheumatology (9)

Public health, health care sciences & services (6)

General & internal medicine (4)

Publications (total 12)

Search in publications

The most downloaded

7 downloads

Bruyère, O., Neuprez, A., Fossi, M., Beaudart, C., Zegels, B., Leonori, L., Hiligsmann, M., & Reginster, J.-Y. (November 2010). Le remboursement des traitements contre l'ostéoporose basé sur l'utilisation de l'outil FRAX plutôt que sur les critères actuels permettrait de réduire de 30% le coût, dans une perspective sociétale, du traitement de l'ostéoporose en Belgique. Revue du Rhumatisme, 77 (Suppl.3), 66-67. https://hdl.handle.net/2268/82829

The most cited

23 citations (Scopus®)

Reginster, J.-Y., Sarlet, N., LEJEUNE, E., & Leonori, L. (March 2005). Strontium Ranelate: A New Treatment for Postmenopausal Osteoporosis with a Dual Mode of Action. Current Osteoporosis Reports, 3 (1), 30-4. doi:10.1007/s11914-005-0025-7 https://hdl.handle.net/2268/25334

Salpetier, P., Mina, M., Seidel, L., LEROY, M., LEONORI, L., Malaise, M., Ribbens, C., & Malaise, O. (2022). Réalisation « systématique » ou « basée sur les recommandations » d’une radiographie du rachis dorsolombaire (Vertebral Fracture Assessment) lors d’un examen de densitométrie osseuse ? Revue du Rhumatisme. doi:10.1016/j.rhum.2022.10.152

https://hdl.handle.net/2268/302897

Peer reviewed

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375.

https://hdl.handle.net/2268/289824

Editorial Reviewed verified by ORBi

Malaise, O., Detroz, M., Leroy, M., Leonori, L., SEIDEL, L., & Malaise, M. (2020). High detection rate of osteoporosis with screening of a general hospitalized population: a 6-year study in 6406 patients in a university hospital setting. BMC Musculoskeletal Disorders, 21 (1), 90. doi:10.1186/s12891-020-3116-9

https://hdl.handle.net/2268/256503

Peer Reviewed verified by ORBi

MALAISE, O., DETROZ, M., LEROY, M., LEONORI, L., SEIDEL, L., & MALAISE, M. (2019). SCREENING FOR OSTEOPOROSIS IN AN AMBULATORY AND HOSPITALIZED POPULATION: A 6- YEAR EXPERIENCE IN A UNIVERSITY HOSPITAL. Annals of the Rheumatic Diseases, 0840. doi:10.1136/annrheumdis-2019-eular.4221

https://hdl.handle.net/2268/268231

Peer Reviewed verified by ORBi

MALAISE, O., Detrooz, M., LEROY, M., LEONORI, L., SEIDEL, L., & MALAISE, M. (2018). Dépistage de l’ostéoporose dans une population ambulatoire et hospitalisée : une expérience de 6 ans au CHU de Liège. Revue du Rhumatisme.

https://hdl.handle.net/2268/268226

Peer Reviewed verified by ORBi

Bruyère, O., Fossi, M., Zegels, B., LEONORI, L., Hiligsmann, M., Neuprez, A., & Reginster, J.-Y. (April 2013). Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria. Rheumatology International, 33 (4), 973-8. doi:10.1007/s00296-012-2460-y

https://hdl.handle.net/2268/128216

Peer Reviewed verified by ORBi

Zegels, B., LEONORI, L., Crozes, P., Uebelhart, D., Bruyère, O., & Reginster, J.-Y. (April 2013). Equivalence of a single dose (1200mg) compared to a 3-time a day dose (400mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis: Results of a randomized double blind placebo controlled study. Osteoporosis International, 24 (Suppl.1), 383.

https://hdl.handle.net/2268/147562

Peer Reviewed verified by ORBi

Bruyère, O., Zegels, B., LEONORI, L., Rabenda, V., Janssen, A., Bourges, C., & Reginster, J.-Y. (March 2012). Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study. Osteoporosis International, 23 (Suppl. 2), 362-363.

https://hdl.handle.net/2268/115405

Peer Reviewed verified by ORBi

Bruyère, O., Neuprez, A., Fossi, M., Zegels, B., LEONORI, L., Hiligsmann, M., & Reginster, J.-Y. (March 2011). Reimbursement of drugs against osteoporosis based on FRAX® instead of the current criteria would reduce by 30% the cost (in a societal perspective) of anti-osteoporosis treatment in Belgium. Osteoporosis International, 22 (Suppl.1), 333-334.

https://hdl.handle.net/2268/88491

Peer Reviewed verified by ORBi

Bruyère, O., Neuprez, A., Fossi, M., Beaudart, C., Zegels, B., Leonori, L., Hiligsmann, M., & Reginster, J.-Y. (November 2010). Le remboursement des traitements contre l'ostéoporose basé sur l'utilisation de l'outil FRAX plutôt que sur les critères actuels permettrait de réduire de 30% le coût, dans une perspective sociétale, du traitement de l'ostéoporose en Belgique. Revue du Rhumatisme, 77 (Suppl.3), 66-67.

https://hdl.handle.net/2268/82829

Peer Reviewed verified by ORBi

Bruyère, O., Kothari, M., Zaim, S., White, D., Peterfy, C., Genant, H. K., Ethgen, D., Montague, T., Burlet, N., LEONORI, L., & Reginster, J.-Y. (March 2005). One-year progression of knee osteoarthritis: correlations between X-Rays and magnetic resonance imaging changes. Osteoporosis International, 16 (Suppl.3), 46-47.

https://hdl.handle.net/2268/86682

Peer Reviewed verified by ORBi

Reginster, J.-Y., Sarlet, N., LEJEUNE, E., & Leonori, L. (March 2005). Strontium Ranelate: A New Treatment for Postmenopausal Osteoporosis with a Dual Mode of Action. Current Osteoporosis Reports, 3 (1), 30-4. doi:10.1007/s11914-005-0025-7

https://hdl.handle.net/2268/25334

Peer Reviewed verified by ORBi